Edition:
India

Roche Holding AG (ROG.S)

ROG.S on Virt-X Level 1

219.25CHF
23 May 2018
Change (% chg)

CHF-4.65 (-2.08%)
Prev Close
CHF223.90
Open
CHF223.50
Day's High
CHF223.90
Day's Low
CHF218.20
Volume
2,068,091
Avg. Vol
2,058,365
52-wk High
CHF269.50
52-wk Low
CHF212.45

Chart for

About

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas:... (more)

Overall

Beta: 0.97
Market Cap(Mil.): CHF214,033.70
Shares Outstanding(Mil.): 862.56
Dividend: 8.20
Yield (%): 3.31

Financials

  ROG.S Industry Sector
P/E (TTM): 22.03 30.95 32.75
EPS (TTM): 11.25 -- --
ROI: 20.46 14.84 14.38
ROE: 46.88 16.34 16.07

Deals of the day-Mergers and acquisitions

May 24 The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Thursday:

24 May 2018

Vontobel's move for Notenstein shakes up Swiss private banking

ZURICH Private bank Vontobel is buying smaller competitor Notenstein La Roche from Swiss cooperative bank Raiffeisen [RFSHW.UL] for $705 million, the first in what industry insiders expect could be a new wave of consolidation in the sector.

24 May 2018

UPDATE 2-Vontobel's move for Notenstein shakes up Swiss private banking

* Industry insiders expect more consolidation among private banks (Adds CEO comments, details, background, shares)

24 May 2018

Swiss stocks - Factors to watch on May 24

ZURICH, May 24 The Swiss blue-chip SMI was seen opening 0.3 percent higher at 8,817 points on Thursday, according to premarket indications by bank Julius Baer .

24 May 2018

Vontobel buys private bank Notenstein La Roche for 700 mln Sfr

ZURICH, May 24 Swiss private bank and asset manager Vontobel is buying private bank Notenstein La Roche from Swiss cooperative bank Raiffeisen for 700 million Swiss francs ($705.08 million), the two parties said on Thursday.

24 May 2018

Roche says has had no contact with Trump lawyer Cohen

ZURICH, May 17 Roche has had no contact with U.S. President Donald Trump's personal attorney Michael Cohen, the Swiss pharmaceuticals maker's Chief Executive said on Thursday.

17 May 2018

Swiss stocks - Factors to watch on May 17

ZURICH, May 17 The Swiss blue-chip SMI was seen opening 0.2 percent higher at 8,988 points on Thursday, according to premarket indications by bank Julius Baer .

17 May 2018

Swiss stocks - Factors to watch on May 17

ZURICH, May 17 Here are some of the main factors that may affect Swiss stocks on Thursday:

17 May 2018

Roche immunotherapy combination increases lung cancer survival - study

Roche's immunotherapy Tecentriq, given with its older drug Avastin and chemotherapy, improved survival of advanced lung cancer patients by about 30 percent over the combination without Tecentriq, according to interim results of a late stage trial released on Wednesday.

17 May 2018

Roche immunotherapy combination increases lung cancer survival-study

May 16 Roche's immunotherapy Tecentriq, given with its older drug Avastin and chemotherapy, improved survival of advanced lung cancer patients by about 30 percent over the combination without Tecentriq, according to interim results of a late stage trial released on Wednesday.

17 May 2018

Earnings vs. Estimates